Worried About Alzheimer’s? Start Walking, According To A New 10-Year Study

If you needed another reason to get your daily steps in, science just handed you one. A new study shows that walking daily can reduce the risk of cognitive decline — especially among those with a genetic predisposition for Alzheimer’s disease. Almost 3,000 participants between the ages of 70 and 79 reported their daily walking habits over ...

Read More

IRS Employer Health Insurance ‘Pay-Or-Play’ Penalties To Rise 15.2% In 2026

The new numbers will affect what some employers owe if employees apply, and get, federal premium subsidies.

Read More

Health Insurance Companies Have A Problem — People Are Using Their Plans More

When medical insurance provider Centene (CNC) opened its books to investors on Friday, the company reported a surprising loss and an uptick in usage. The latter is a broader problem for the industry. In the second quarter, Centene reported an adjusted loss of $79 million and a “health benefits ratio” of 93%. Its benefits ratio, or the ...

Read More

High Part D Premium Hikes In CMS’ Crosshairs For 2026 Bids

The Centers for Medicare & Medicaid Services has published its preliminary technical Medicare Part D bid information for the 2026 contract year, with updates intended to limit significant increases in cost-sharing and premium hikes. The changes in how CMS approves certain standalone prescription drug plan (PDP) sponsors have resulted in the first-ever rejections of standalone PDP bids. ...

Read More

EU-US Trade Deal Could Add Up To $19 Billion In Pharma Industry Costs, Analysts Say

The European Union’s trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday. The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the ...

Read More

Benefits Council Asks Congress To Restore Expanding 340B Program To Its Original Intent

The American Benefits Council is urging Congress to consider the cost to employers, workers and their families as it proposes changes to the 340B drug pricing program.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square